Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01428193 · ClinicalTrials.gov registry record · NA
Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone
A NA study, sponsored by University of Virginia.
- Terminated
- Registry status
- NA
- Development phase
- 4
- Enrollment target
NCT01428193 is a NA study that was terminated before completion, run by University of Virginia. The registered enrollment target is 4 participants.
The verdict
NCT01428193, a NA study, was terminated before completion, sponsored by University of Virginia.
- TERMINATED
- Registry status
- NA
- Development phase
- 4 participants
- Enrollment target
Study Summary
The purpose of this study is to understand the effects of elevated male hormones in adolescent girls and how they effect the development of polycystic ovary syndrome (PCOS). If the investigators understand the effects of elevated male hormones levels in girls, the investigators may be able to better treat girls with elevated male hormone levels and perhaps even learn how to prevent the development of PCOS. Females with elevated levels of male hormones respond differently to estrace (estradiol) and progesterone than females with normal male hormone levels. The investigators will be giving you estrogen and progesterone to see how you respond after the male hormone has been blocked by a medication called flutamide.
Interventions
- DRUG Progesterone
- DRUG Flutamide
- DRUG estrace
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 4 participants |
| Start Date | 2006-09 |
| Est. Completion | 2017-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01428193
The ClinicalTrials.gov registry entry for NCT01428193 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 4 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Virginia, which has 449 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Progesterone is the first listed.
NCT01428193 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01428193 about?
NCT01428193 is a clinical study titled "Effects of Androgen Blockade on Sensitivity of the GnRH Pulse Generator to Suppression by Estradiol and Progesterone". The purpose of this study is to understand the effects of elevated male hormones in adolescent girls and how they effect the development of polycystic ovary syndrome (PCOS). If the investigators understand the effects of elevated male hormones levels in girls, the investigators may be able to better...
What is the current status of trial NCT01428193?
This trial is currently terminated. It is a NA study. The enrollment target is 4 participants. The study started on 2006-09. Estimated completion is 2017-08.
What interventions are being tested in trial NCT01428193?
The interventions under investigation include: Progesterone (DRUG), Flutamide (DRUG), estrace (DRUG).
Who is sponsoring clinical trial NCT01428193?
This trial is sponsored by University of Virginia, which has 449 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.